Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test

被引:0
|
作者
Binefa, Gemma [1 ,2 ]
Garcia, Montse [1 ]
Mila, Nuria [1 ]
Rodriguez, Lorena [3 ]
Rodriguez-Moranta, Francisco [3 ]
Guardiola, Jordi [3 ]
Moreno, Victor [1 ,2 ]
机构
[1] IDIBELL, Inst Catalan Oncol, Canc Prevent & Control Programme, Barcelona, Spain
[2] Univ Barcelona, Dept Clin Sci, Barcelona, Spain
[3] Hosp Univ Bellvitge, IDIBELL, Endoscopy Unit, Barcelona, Spain
关键词
Colonoscopy; Quality indicators; Colorectal cancer; Mass screening programme; COLORECTAL-CANCER; ADENOMA DETECTION; RISK; INDICATORS; ASSURANCE; ROUNDS;
D O I
10.4321/S1130-01082013000700005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: the success of colorectal cancer (CRC) screening programmes largely depends on the quality of the events, processes and outcomes and therefore, quality assurance of endoscopy is an essential component. The quality indicators for colonoscopy in a screening programme setting are different from those performed in symptomatic people. The objective of this study was to report the main quality indicators of colonoscopies performed after a positive faecal occult blood test (FOBT) in a CRC screening programme in Catalonia. Methods: the period of study includes three rounds of the CRC screening programme from June 2006 to July 2013. Two types of FOBT were used: a qualitative biochemical guaiac-based test (gFOBT) and a quantitative immunochemical test (FIT). Quality indicators analysed in this study were compared to recommended colonoscopy standards from the published guidelines. Results: during the study period, 1,806 colonoscopies were performed in 1,691 individuals with a positive FOBT. All indicators were within the standard except waiting time to colonoscopy. Caecal intubation rate was 95.6 % and adequate bowel cleansing 93.6 %. Adenoma detection rate was better using FIT than gFOBT, 30.7 and 3.8 per 1,000 screenees, respectively. Cancer detection rate was also greater using FIT. Nearly 62 % of cancers were diagnosed at an early stage. The overall complication rate was 10.7 parts per thousand. Conclusion: although the majority of results reached the recommended standards, some areas have been identified for quality enhancement. Continuous monitoring of quality indicators is essential for improving the current effectiveness of CRC screening programmes.
引用
收藏
页码:400 / 408
页数:9
相关论文
共 50 条
  • [1] Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: A population-based cohort study
    Denis, Bernard
    Gendre, Isabelle
    Sauleau, Erik Andre
    Lacroute, Joel
    Perrin, Philippe
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (06) : 474 - 480
  • [2] Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology
    Bampton, PA
    Sandford, JJ
    Cole, SR
    Smith, A
    Morcom, J
    Cadd, B
    Young, GP
    [J]. GUT, 2005, 54 (06) : 803 - 806
  • [3] Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening
    Clarke, P
    Jack, F
    Carey, FA
    Steele, RJC
    [J]. COLORECTAL DISEASE, 2006, 8 (05) : 389 - 392
  • [4] Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy)
    Zorzi, Manuel
    Senore, Carlo
    Da Re, Filippo
    Barca, Alessandra
    Bonelli, Luigina Ada
    Cannizzaro, Renato
    Fasoli, Renato
    Di Furia, Lucia
    Di Giulio, Emilio
    Mantellini, Paola
    Naldoni, Carlo
    Sassatelli, Romano
    Rex, Douglas
    Hassan, Cesare
    Zappa, Marco
    [J]. GUT, 2015, 64 (09) : 1389 - 1396
  • [5] Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer
    Parente, F.
    Marino, B.
    DeVecchi, N.
    Moretti, R.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (05) : 533 - 540
  • [6] COLONOSCOPY COMFORT AND SUBSEQUENT FAECAL OCCULT BLOOD SCREENING UPTAKEIN THE ENGLISH BOWEL CANCER SCREENING PROGRAMME
    Lo, S. H.
    Ghanouni, A.
    Rees, C.
    Rutter, M.
    Snowball, J.
    Seaman, H.
    Halloran, S.
    Wardle, J.
    von Wagner, C.
    [J]. GUT, 2015, 64 : A373 - A373
  • [7] How Good is the Guaiac-based Faecal Occult Blood Test for Population Screening?
    Halloran, S. P.
    Snowball, J.
    Slyfield, J.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (06) : A117 - A118
  • [8] Experience with a wipe guaiac-based faecal occult blood test as an alternative test in a bowel screening programme
    Fraser, C. G.
    McDonald, P. J.
    Colford, L.
    Irvine, A.
    Kenicer, M.
    Morton, C.
    Birrell, J.
    Steele, R. J. C.
    [J]. JOURNAL OF MEDICAL SCREENING, 2010, 17 (04) : 211 - 213
  • [9] Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme
    G Castiglione
    C B Visioli
    S Ciatto
    G Grazzini
    A G Bonanomi
    T Rubeca
    P Mantellini
    M Zappa
    [J]. British Journal of Cancer, 2007, 96 : 1750 - 1754
  • [10] Colorectal cancer screening: Barriers to the faecal occult blood test (FOBT) and colonoscopy in Singapore
    Yong, Sook Kwin
    Ong, Whee Sze
    Koh, Gerald Choon-Huat
    Yeo, Richard Ming Chert
    Ha, Tam Cam
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2016, 25 (04) : 207 - 214